Filing Details
- Accession Number:
- 0000721371-24-000085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-19 20:28:07
- Reporting Period:
- 2024-08-15
- Accepted Time:
- 2024-08-19 20:28:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
721371 | Cardinal Health Inc | CAH | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 310958666 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741576 | E Aaron Alt | 7000 Cardinal Place Dublin OH 43017 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2024-08-15 | 14,271 | $0.00 | 41,671 | No | 4 | A | Direct | |
Common Shares | Disposition | 2024-08-16 | 2,481 | $107.91 | 39,190 | No | 4 | F | Direct | |
Common Shares | Disposition | 2024-08-19 | 2,323 | $108.91 | 36,867 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2025.
- Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 5,531 RSUs.
- Reflects closing price on prior business day.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.82 to $108.99, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.